DRD4

gene product
This gene encodes the D4 subtype of the dopamine receptor. The D4 subtype is a G-protein coupled receptor which inhibits adenylyl cyclase. It is a target for drugs which treat schizophrenia and Parkinson disease. Mutations in this gene have been associated with various behavioral phenotypes, including autonomic nervous system dysfunction, attention deficit/hyperactivity disorder, and the personality trait of novelty seeking. This gene contains a polymorphic number (2-10 copies) of tandem 48 nt repeats; the sequence shown contains four repeats. [provided by RefSeq, Jul 2008]
More gene data

Featured antibodies

Antibodies

 

Filters

Antibodypedia Validation Initiative

Validation method

Application

Reference

Provider

Host

Reactivity

Antibody type

Conjugate

  or   Clear
Validated by best practice
Supportive data in Antibodypedia
Data presented on provider website
Data in Antibodypedia (inconclusive)
Recommended by provider
Validated within AVI
Eligible for validation within AVI
335 antibodies from 24 providers.

Antibody properties

Applications

or Cancel
AntibodyRefsTypeAVIWBELICCIPIHCFC
Abgent
6 antibodies
Novus Biologicals
3 antibodies
antibodies-online
105 antibodies
Aviva Systems Biology
6 antibodies
Biorbyt
16 antibodies
LifeSpan BioSciences, Inc.
38 antibodies
GeneTex
6 antibodies
Arigo
1 antibody
Bioworld Technology, Inc
2 antibodies
Acris Antibodies GmbH
10 antibodies
FabGennix
3 antibodies
NovoPro Bioscience Inc.
4 antibodies
Abnova Corporation
3 antibodies
Invitrogen Antibodies
4 antibodies
MyBioSource
11 antibodies
Creative Biolabs
3 antibodies
St John's Laboratory
2 antibodies
United States Biological
91 antibodies
EMD Millipore
3 antibodies
Creative Diagnostics
2 antibodies
RayBiotech, Inc.
2 antibodies
Everest Biotech
1 antibody
Sigma-Aldrich
1 antibody